Answers are grounded in this paper and cite their sources.
Human immunodeficiency virus (HIV) is the causative agent of acquired immune deficiency syndrome (AIDS). Anti-HIV agents targeting various steps in HIV life cycle have been developed; however, so far, no effective drugs have been found. We show here that a peptide isolated from Spirulina maxima (SM-peptide) inhibits HIV-1 infection in a human T cell line MT4. SM-peptide inhibited HIV-1 IIIB -induced cell lysis with a half-maximal inhibitory concentration (IC 50 ) of 0.691 mM, while its 50 % cytotoxic concentration (CC 50 ) was greater than 1.457 mM. Furthermore, the SM-peptide inhibited the HIV-1 reverse transcriptase activity and p24 antigen production. This suggests that SM-peptide is a novel candidate peptide, which may be developed as a therapeutic agent for acquired immunodeficiency syndrome patients.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: